Rowpar Pharmaceuticals CEO Dr. James Ratcliff is taking the company’s CloSYS oral hygiene brands into China—during a trade war. He talks with us about the challenges in doing so.
Many CEOs at U.S.-based manufacturers are applauding President Trump's attempt to disrupt and overturn a global trade milieu of long standing that they believe has greatly disadvantaged American companies and exports overall.
In response to the U.S. corporate tax overhaul, China has temporarily waived income taxes for foreign manufacturers on profits those companies reinvest in their country.
The China-led Belt and Road project will present opportunities for many types of business around the world. Here's some tips for getting involved.
Its economy may be slowing and hostility towards foreign entrants may be on the rise. But that isn't necessarily ending American CEOs' Chinese dreams.
The president is talking tough ahead of this week's meeting, which could offer room for both leaders to advance their mutual interests—and help business in the process.
U.S. companies are still attempting to embrace the benefits of globalization, no matter what the political climate.
Pacific Rim leaders have vowed to press on with free-trade negotiations, though they could now have a greater focus on China, rather than the U.S, following Donald Trump's election as president.
For the growing number of U.S. businesses concerned about the safety risks of operating in China, the sudden arrest of one of Australia's highest-ranking casino executives will do little to quell their fears.
China's economic development is at a crossroads, leaving CEOs around the world fearful a recession there could drag their businesses into the red.